failure – Page 31 – Communicable Diseases Research

muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial

코비드-19-실험 약물 및 기전(TACTIC-E)으로 입원한 ICu 전 환자에 대한 다중 암 치료 연구: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2020-07-312022-08-13
Journal: Trials [Category] SARS, 임상,

Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease

Research Article

Published on 2020-07-232022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,

[키워드] Abnormalities abnormality appear Arrhythmias assessment baseline Blood caused changes in Clinical data Clinical outcome coronavirus 2019 disease coronavirus disease Course COVID-19 diarrhea died dose evaluate failure grade 3 HCQ HCQ therapy highlighting Hospitalization hospitalized patient hospitals Hydroxychloroquine hypoxia IMPROVE in vitro activity in-hospital mortality incident liver mechanical ventilation New York City occurred outcomes Patient proportion QT prolongation randomized trials receiving requiring supplemental oxygen Respiratory Coronavirus Result retrospective cohort study Safe Safety SARS-CoV-2 supplemental oxygen sustained therapy Tolerability tolerable Treatment ventricular vomiting with COVID-19 worldwide pandemic
[DOI] 10.1371/journal.pone.0236778 PMC 바로가기 [Article Type] Research Article

A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-07-132022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] 24 hour 48 hour Activation acute lung injury acute pneumonia acute respiratory distress syndrome Administered Adult age all-cause mortality Amendment antibodies antibody Antibody test anticipated antiviral therapy approval ARDS assessment assigned baseline Biomarker Blood cardiac disease Care change class Clinical improvement clinical study clinical trial complement Complement inhibitor component Computed tomography concealed Concentration conducted Confirmed Controlled coronary syndrome COVID-19 criteria current Day diagnosis of SARS-CoV-2 dialysis discharge dissemination dose Duration Efficacy element eligibility Endotracheal intubation EU Clinical Trial EudraCT evaluate the effect expected failure female patient Final fraction France Germany greater half-live hospital Hospitalization humanized Hypercoagulable state Immunoglobulin Infection Inflammatory inhibitor initiated intensive care Intubated intubation invasive Invasive mechanical ventilation investigator IVIG Japan Lung injury mechanical ventilation medication monoclonal multicenter Neisseria meningitidis Non-invasive number objective Open-label original outcome oxygen participant Patient patients randomized patients with COVID-19 Period peripheral capillary phase Placebo Pneumonia polymerase chain positive airway pressure presenting progression protocol randomised randomised controlled trial randomization randomization list Randomized randomized controlled study Randomly Ravulizumab receive recruitment registry Remdesivir renal respiratory respiratory distress Respiratory distress syndrome routine clinical care Safety screened Screening secondary Serious Adverse Events serum severe acute respiratory distress syndrome coronavirus 2 Severe acute respiratory syndrome severe COVID-19 severe pneumonia SOFA Spain SpO2 Sponsor stratified Study protocol supportive care survival The United States therapy time Treatment treatment-emergent adverse event Ultomiris United Kingdom ventricular Viral website with COVID-19 X-ray
[DOI] 10.1186/s13063-020-04548-z PMC 바로가기 [Article Type] Letter

National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 – a prospective cohort study

Original Research

Published on 2020-07-132022-10-29
Journal: Scandinavian Journal of Trauma, Resuscitation and [Category] COVID-19, SARS,

The Successes and Failures of the Initial COVID-19 Pandemic Response in Romania

Public Health

Published on 2020-07-102022-10-31
Journal: Frontiers in Public Health [Category] COVID-19, MERS,

High Inflammatory Burden: A Potential Cause of Myocardial Injury in Critically Ill Patients With COVID-19

Cardiovascular Medicine

Published on 2020-07-072022-10-31
Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19,

[키워드] addition Admission age analyzed assessment cause chronic Clinical characteristics cohort study Comorbidity confidence interval correlation COVID-19 COVID-19 patient Cox regression critical patients Critically ill patient death demographic develop diagnosed enrolled exceeded failure had more hazard ratio high mortality high mortality rate High-sensitivity C-reactive protein IL-10 IL-6 IL-8 Ill In-ICU mortality incidence independent risk factor Inflammation Inflammatory Injury Laboratory tests limits Logistic regression median Mortality myocardial injury novel coronavirus disease Occurrence Odds ratio Older outcome Patient patients patients with COVID-19 Physiology plasma Plasma level positively correlated Potential receptor retrospective risk factor score significantly higher single-center smoking statistically suggested the mean TNF-α tumor necrosis factor-α two group with COVID-19
[DOI] 10.3389/fcvm.2020.00128 PMC 바로가기 [Article Type] Cardiovascular Medicine

Kidney Replacement Therapy in COVID-19 Induced Kidney Failure and Septic Shock: A Pediatric Continuous Renal Replacement Therapy [PCRRT] Position on Emergency Preparedness With Resource Allocation

Pediatrics

Published on 2020-07-032022-10-31
Journal: Frontiers in Pediatrics [Category] COVID-19,

Failure of early extubation among cases of coronavirus disease-19 respiratory failure Case report and clinical experience

3900

Published on 2020-07-022022-10-30
Journal: Medicine [Category] COVID-19, SARS,

[키워드] adopted Antiviral Antiviral treatment Care carried chronic obstructive clinical experience conducted coronavirus disease 19 Coronavirus disease-19 criteria Elderly patient Endotracheal intubation expected extracorporeal membrane oxygenation extubation extubation criteria failure Hospitalization iatrogenic Infection Injury intubation likelihood mechanical ventilation mechanically ventilated patient noninvasive respiratory onset of fever Oxygenation Patient progressed progression Prone position pulmonary disease receive receiving reduce rehabilitation reintubation reported Respiratory failure sputum Strategy Support Supportive treatment symptomatic the disease therapy tracheal transferred Treatment upper respiratory tract Viral pneumonia was performed
[DOI] 10.1097/MD.0000000000020843 PMC 바로가기 [Article Type] 3900

Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review

Review

Published on 2020-06-302022-10-29
Journal: International Journal of Molecular Sciences [Category] COVID-19, SARS,

Variation in Ventilator Allocation Guidelines by US State During the Coronavirus Disease 2019 Pandemic A Systematic Review

Research

Published on 2020-06-192022-10-29
Journal: JAMA Network Open [Category] Coronavirus, SARS,